Involvement of lipid peroxidation, oncogene expression and induction of apoptosis in the antitumorous activity of ferric-sorbitol-citrate

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 3, 2000, Pages 285-293

  Poljak Blaži, Marija ^a   Kralj, Marijeta ^a   Hadžija, Marijana Popović ^a   Žarković, Neven ^a   Žarković, Kamalija ^b   Waeg, Georg ^c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

4 Hydroxynonenal (HNE); Apoptosis; Bcl 2; C myc; Colon carcinoma cell line; Ferric sorbitol citrate (FSC); Ferritin; Growth modulation; Iron; Oncogenes; Oxidative stress; P53

Indexed keywords

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLON CARCINOMA; HUMAN; HUMAN CELL; LIPID PEROXIDATION; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0033854913     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497800414383     Document Type: Article

References (30)

1. Williams RJP. Haem-proteins and oxygen. In: Jacobs A, Worwood M (eds): Iron in Biochemistry and Medicine, London, UK, Academic Press, 1974, p. 183.
2. Tillian HM, Hammer A, Kink E, et al. Iron-induced lipid peroxidation and inhibition of proliferation of Ehrlich ascites tumour cells. J Cancer Res Clin Oncol 1989; 115: 79.
3. Floyd RA. Role of oxygen free radicals in cancerogenesis and brain ischemia. FASEB J 1990; 4: 2587.
4. Toyokuni S, Uchida K, Hattori-Nakakuki Y, et al. Formation of 4-hydroxy-2-nonenal-modified proteins in renal proximal tubules of rats treated with renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 2616.
5. 16 growth. Period Biol 1985; 87: 17.
6. Flajsig I, Poljak-Blaži M: Influence of iron on proliferation and cell cycle kinetics on cultured malignant and nonmalignant cells. Oncology 1990; 47: 443.
7. Poljak-Blaži, M., Zarković, N, Schaur RJ. Impaired proliferation and DNA synthesis of a human tumour cell line (HeLa) caused by a short treatment with antianaemic drug Jectofer (ferric-sorbitol-citrate) and the lipid peroxidation product 4-hydroxinonenal. Cancer Biother Radioph 1998; 13:395.
8. Penn LJZ, Brooks MW, Laufer EM, Land H. Negative auto-regulation of c-myc transcription. EMBO J 1990;4:1113.
9. Freytag OS, Dang VC, Lee MFW. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differentiation 1:339-343, 1990.
10. Haffner, R. and Oren M. p53 biochemical properties and biological effects. Curr Opin Genet Dev 1995;9:84.
11. Oren M. Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 1994;5:3051.
12. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back on the future. FEBS Lett 1996;396: 7.
13. Reed CJ. Double identity for proteins of the Bcl-2 family. Nature 1997;387: 773.
14. Balla G, Jacob HS, Balla J, Rosenberg M, Noth K, Apple F, Eaton JW, and Vercelotti GM: Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 1992;267: 18148.
15. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11: 81.
16. Schauenstein E, Esterbauer H, Zollner H. Aldehydes in biological systems; their natural occurrence and biological activities. London, Pion Ltd, 1977.
17. Schaur RJ, Zollner H, Esterbauer H. Biological effects of aldehydes with particular attention to 4-hydroxynonenal and malonaldehyde. In: Vigo-Pelfrey C (ed): Membrane lipid oxidation, Vol. III, Boca Raton, Florida, CRC Press, Inc, 1991; pp 141.
18. Herrmann M, Lorenz H-M, Voll R, et al. Rapid and simple method for the isolation of apoptotic DNA fragments. Nuc Acid Res 1994;22: 5506.
19. Kranz BR, Thiel E, Thierfelder S. Immunocytochemical identification of meningeal leukaemia and lymphoma: Poly-L-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens. Blood 1989;73:194.
20. Weag, G. Dimsity G, Esterbauer H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 1996;25: 149.
21. Žarković K, Žarković N, Schlag G, Redl H, and Waeg G: Histological aspects of sepsis-induced brain changes in a baboon model. In: G Schlag, H. Redl, D.L. Traber (eds): Shock, Sepsis and Organ Failure. Heidelberg, Springer-Verlag, 1997; p. 146.
22. Yang HB, Hsu PI, Lee JC, Chan SHLin XZ, Chow NH. Adenoma-carcinoma sequence: A reappraisal with immunohistochemical expression of ferritin. J Surg Oncol 1995; 60: 35.
23. Haupt Y, Rowan S, Shaulian S, et al. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev 1995;9: 2170.
24. Hakem R, Hakem A, Duncan GS, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998;94: 339.
25. Krajewski S, Tanaka S, Takayama S, Schibler JM, Fenton W, Reed CJ. Investigation of the subcellular distribution of the BCL-2 oncoprotein: Residance in the nuclear envelope, endoneoplasmic reticulum and outer mitochondrial membranes. Cancer Res 1993;53: 4701.
26. Lotem J, Peledkamar M, Groner Y, Sachs L. Cellular oxidative stress and the control of apoptosis by wildtype p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 1996;93: 9166.
27. Fazio VM, Rinaldi M, Ciafre S, et al. Control of neoplastic cell proliferation and differentiation by restoration of 4-hydroxynonenal physiological concentrations. Molec Aspects Med 1993;14: 217.
28. Žarković N, Ilić Z, Jurin M, Schaur R J, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochemistry Function 1993;11: 279.
29. Vaughn CB, Weinstein R, Bond B, Rice R, Vaughn RW, McKendrick A, Ayad G, Rockwell MA, Rosshio R. Feritin content in human cancerous and noncancerous colonie tissue. Cancer Invest 1987;5:7.
30. Weinstein Re, Bond BH, Silberberg BK, Vaugh CB, Subbaiah P, Piper DR. Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res. Treatment 1989;14: 349.